SCHEMBL15915979

SCHEMBL15915979

N#CCCN(C1CC1)S(=O)(=O)c1ccccc1Br

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.58
ATM Q13315 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.53
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALOX5AP P20292 2/20 0.51
FEN1 P39748 2/20 0.51
MAPT P10636 2/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 2/20 0.39
PLCG1 P19174 1/20 0.38
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15916790 0.76 TDP1 (0.69) TDP1ATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL17479169 0.74 TDP1 (0.66) TDP1ATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL2335331 0.72 PSEN1 (0.53) L3MBTL1ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL2335117 0.70 HTR2A (0.54) TDP1ATML3MBTL1ALDH1A1MAPT
SCHEMBL14419645 0.69 ALDH1A1 (0.47) TDP1ALDH1A1SMN1; SMN2ALOX5APFEN1
SCHEMBL1645104 0.68 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2ALOX5APFEN1MAPT
SCHEMBL2964684 0.67 L3MBTL1 (0.49) TDP1ATML3MBTL1MAPTKMT2A
SCHEMBL15916018 0.66 L3MBTL1 (0.45) TDP1ATML3MBTL1ALOX5APFEN1
SCHEMBL6020272 0.65 RECQL (0.57) ALOX5APFEN1MAPTKMT2APLCG1
SCHEMBL15915954 0.65 PLCG1 (0.62) TDP1L3MBTL1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495359-A1 FLAP MODULATORS Janssen Pharmaceutica NV (BE) 2019-06-12 EP disclosed
EP-3070085-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-01-09 EP disclosed
EP-2951170-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-10-24 EP disclosed
US-9884878-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2018-02-06 US disclosed
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 US disclosed
EP-3070085-A1 FLAP MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-09-21 EP disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 US disclosed
US-20150259357-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-17 US disclosed
US-9079866-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-14 US disclosed
US-20140221311-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R TDP1 355/4885ATM 2412/4885L3MBTL1 2429/4885
US-20150259357-A1 FLAP MODULATORS PGF, FEN1, TBXA2R TDP1 646/4885ATM 2103/4885L3MBTL1 2907/4885
US-20140221311-A1 FLAP MODULATORS PGF, FEN1, TBXA2R TDP1 646/4885ATM 2103/4885L3MBTL1 2907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.